• Nenhum resultado encontrado

Co- transplantation of Bone Marrow Stromal Cells with Schwann Cells Evokes Mechanical Allodynia in the Contusion Model of Spinal Cord Injury in Rats

N/A
N/A
Protected

Academic year: 2017

Share "Co- transplantation of Bone Marrow Stromal Cells with Schwann Cells Evokes Mechanical Allodynia in the Contusion Model of Spinal Cord Injury in Rats "

Copied!
10
0
0

Texto

Loading

Imagem

Fig 1: Schwann cells and bone marrow stromal cells in cul- cul-ture. (A) Schwann cells (×200) and (B) bone marrow stromal  cells are shown in late stage of subculture (× 200) .
Fig  3:  The  bar  graph  representing  the  assessment  of  motor  function  recovery  by  BBB  scores  following  cell   transplanta-WLRQ(LJKWZHHNVDIWHUFHOOWUDQVSODQWDWLRQWKHUHLVVLJQL¿FDQW difference between experimental and sham groups (p < 0.05).
Fig  5:  Von  Frey  Filaments  for  assessment  of  mean  with- with-drawal threshold and mechanical allodynia.

Referências

Documentos relacionados

Transplantation of Bone Marrow – Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats.. Transplantation of Bone Marrow-Derived Mononuclear Cells Improves

A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth stem cells, dental pulp stem cells, or bone marrow-derived mesenchymal stem cells for

Conditioned medium from bone marrow- derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell

Characterization of equine adipose tissue-derived stromal cells: Adipogenic and osteogenic capacity and comparison with bone marrow derived mesenchymal stromal

Primary human bone marrow stromal cells (hMSCs) were transfected with human telomerase reverse transcriptase (hTERT) gene with lipofection method.. The hTERT transfected hMSCs

Silencing SOX2 expression in neural crest stem cells may reverse the inhibition of differentiation from neural crest stem cells to Schwann cells conducted by

Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. Human mesenchymal stem cells